2014 Female Athlete Triad Coalition Consensus Statement on Treatment and Return to Play of the Female Athlete Triad: 1st International conference held in San Francisco, California, May 2012 and 2nd International conference held in Indianapolis, Indiana, May 2013

British Journal of Sports Medicine

Volumn 48, Issue 4, 2014, Pages 289-

  De Souza, Mary Jane ^a   Nattiv, Aurelia ^b   Joy, Elizabeth ^c   Misra, Madhusmita ^d   Williams, Nancy I ^a   Mallinson, Rebecca J ^a   Gibbs, Jenna C ^e   Olmsted, Marion ^f   Goolsby, Marci ^g   Matheson, Gordon ^h  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c INTERMOUNTAIN HEALTHCARE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF WATERLOO   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g HOSPITAL FOR SPECIAL SURGERY   (United States)

^h STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANAMNESIS; ATHLETIC PERFORMANCE; BONE DENSITY; CHILD; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; CONVALESCENCE; EARLY DIAGNOSIS; ENERGY METABOLISM; FEMALE; FEMALE ATHLETE TRIAD; HEALTH STATUS; HUMAN; METHODOLOGY; PATIENT CARE; PATIENT CARE PLANNING; PATIENT SELECTION; PHOTON ABSORPTIOMETRY; PHYSIOLOGY; PRACTICE GUIDELINE; RISK ASSESSMENT; SPORTS MEDICINE; TREATMENT OUTCOME; UNITED STATES; WOMEN IN SPORT; YOUNG ADULT;

WOMEN IN SPORT;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; ADULT; ATHLETIC PERFORMANCE; BONE DENSITY; CHILD; EARLY DIAGNOSIS; ENERGY METABOLISM; FEMALE; FEMALE ATHLETE TRIAD SYNDROME; HEALTH STATUS; HUMANS; INDIANA; MEDICAL HISTORY TAKING; PATIENT CARE PLANNING; PATIENT CARE TEAM; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; RECOVERY OF FUNCTION; RISK ASSESSMENT; SAN FRANCISCO; SPORTS MEDICINE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84893498779     PISSN: 03063674     EISSN: 14730480     Source Type: Journal    
DOI: 10.1136/bjsports-2013-093218     Document Type: Article

References (242)

1. McCrory P, Meeuwisse W, Johnston K, et al. Consensus Statement on Concussion in Sport: the 3rd International Conference on Concussion in Sport held in Zurich, November 2008. Br J Sports Med 2009;43(Suppl 1):i76-90.
2. Nattiv A, Loucks AB, Manore MM, et al. American College of Sports Medicine position stand. The female athlete triad. Med Sci Sports Exerc 2007;39:1867-82.
3. Otis CL, Drinkwater B, Johnson M, et al. American College of Sports Medicine position stand. The female athlete triad. Med Sci Sports Exerc 1997;29:i-ix.
4. De Souza MJ, Lee DK, Van Heest JL, et al. Severity of energy-related menstrual disturbances increases in proportion to indices of energy conservation in exercising women. Fertil Steril 2007;88:971-5.
5. Williams NI, Helmreich DL, Parfitt DB, et al. Evidence for a causal role of low energy availability in the induction of menstrual cycle disturbances during strenuous exercise training. J Clin Endocrinol Metab 2001;86:5184-93.
6. Loucks AB, Thuma JR. Luteinizing hormone pulsatility is disrupted at a threshold of energy availability in regularly menstruating women. J Clin Endocrinol Metab 2003;88:297-311.
7. De Souza MJ, West SL, Jamal SA, et al. The presence of both an energy deficiency and estrogen deficiency exacerbate alterations of bone metabolism in exercising women. Bone 2008;43:140-8.
8. De Souza MJ, Williams NI. Beyond hypoestrogenism in amenorrheic athletes: energy deficiency as a contributing factor for bone loss. Curr Sports Med Rep 2005;4:38-44.
9. Ihle R, Loucks AB. Dose-response relationships between energy availability and bone turnover in young exercising women. J Bone Miner Res 2004;19:1231-40.
10. Mallinson RJ, Williams NI, Hill BR, et al. Body composition and reproductive function exert unique influences on indices of bone health in exercising women. Bone 2013;56:91-100.
11. De Souza MJ, Miller BE, Loucks AB, et al. High frequency of luteal phase deficiency and anovulation in recreational women runners: blunted elevation in follicle-stimulating hormone observed during luteal-follicular transition. J Clin Endocrinol Metab 1998;83:4220-32.
12. De Souza MJ, Toombs RJ, Scheid JL, et al. High prevalence of subtle and severe menstrual disturbances in exercising women: confirmation using daily hormone measures. Hum Reprod 2010;25:491-503.
13. Tomten SE, Falch JA, Birkeland KI, et al. Bone mineral density and menstrual irregularities. A comparative study on cortical and trabecular bone structures in runners with alleged normal eating behavior. Int J Sports Med 1998;19:92-7.
14. Sowers M, Randolph JF Jr, Crutchfield M, et al. Urinary ovarian and gonadotropin hormone levels in premenopausal women with low bone mass. J Bone Miner Res 1998;13:1191-202.
15. Field AE, Gordon CM, Pierce LM, et al. Prospective study of physical activity and risk of developing a stress fracture among preadolescent and adolescent girls. Arch Pediatr Adolesc Med 2011;165:723-8.
16. Tenforde AS, Sayres LC, McCurdy ML, et al. Identifying sex-specific risk factors for stress fractures in adolescent runners. Med Sci Sports Exerc 2013;45:1843-51.
17. Barrack MT, Gibbs JC, De Souza MJ, et al. Higher incidence of bone stress injury with increasing female athlete triad risk factors: a prospective multisite study of exercising girls and women. Am J Sports Med (in press).
18. Nattiv A, Kennedy G, Barrack MT, et al. Correlation of MRI grading of bone stress injuries with clinical risk factors and return to play: a 5-year prospective study in collegiate track and field athletes. Am J Sports Med 2013;41:1930-41.
19. Duckham RL, Peirce N, Meyer C, et al. Risk factors for stress fracture in female endurance athletes: a cross-sectional study. BMJ Open 2012;2:e001920.
20. Kelsey JL, Bachrach LK, Procter-Gray E, et al. Risk factors for stress fracture among young female cross-country runners. Med Sci Sports Exerc 2007;39:1457-63.
21. Lauder TD, Dixit S, Pezzin LE, et al. The relation between stress fractures and bone mineral density: evidence from active-duty army women. Arch Phys Med Rehabil 2000;81:73-9.
22. Rauh MJ, Macera CA, Trone DW, et al. Epidemiology of stress fracture and lower-extremity overuse injury in female recruits. Med Sci Sports Exerc 2006;38:1571-7.
23. Loucks AB, Heath EM. Induction of low-T3 syndrome in exercising women occurs at a threshold of energy availability. Am J Physiol 1994;266(3 Pt 2):R817-23.
24. Loucks AB, Verdun M, Heath EM. Low energy availability, not stress of exercise, alters LH pulsatility in exercising women. J Appl Physiol 1998;84:37-46.
25. Hilton LK, Loucks AB. Low energy availability, not exercise stress, suppresses the diurnal rhythm of leptin in healthy young women. Am J Physiol Endocrinol Metab 2000;278:E43-9.
26. Williams NI, Bullen BA, McArthur JW, et al. Effects of short-term strenuous endurance exercise upon corpus luteum function. Med Sci Sports Exerc 1999;31:949-58.
27. Williams NI, Caston-Balderrama AL, Helmreich DL, et al. Longitudinal changes in reproductive hormones and menstrual cyclicity in cynomolgus monkeys during strenuous exercise training: abrupt transition to exercise-induced amenorrhea. Endocrinology 2001;142:2381-9.
28. Loucks AB. Low energy availability in the marathon and other endurance sports. Sports Med 2007;37:348-52.
29. De Souza MJ, Williams NI. Physiological aspects and clinical sequelae of energy deficiency and hypoestrogenism in exercising women. Hum Reprod Update 2004;10:433-48.
30. Bullen BA, Skrinar GS, Beitins IZ, et al. Induction of menstrual disorders by strenuous exercise in untrained women. N Engl J Med 1985;312:1349-53.
31. O'Donnell E, Harvey PJ, Goodman JM, et al. Long-term estrogen deficiency lowers regional blood flow, resting systolic blood pressure, and heart rate in exercising premenopausal women. Am J Physiol Endocrinol Metab 2007;292:E1401-9.
32. Rickenlund A, Eriksson MJ, Schenck-Gustafsson K, et al. Amenorrhea in female athletes is associated with endothelial dysfunction and unfavorable lipid profile. J Clin Endocrinol Metab 2005;90:1354-9.
33. Vanheest JL, Rodgers CD, Mahoney CE, et al. Ovarian suppression impairs sport performance in junior elite female swimmers. Med Sci Sports Exerc 2014;46:156-66.
34. Becker AE, Grinspoon SK, Klibanski A, et al. Eating disorders. N Engl J Med 1999;340:1092-8.
35. Golden NH, Katzman DK, Kreipe RE, et al. Eating disorders in adolescents: position paper of the Society for Adolescent Medicine. J Adolesc Health 2003;33:496-503.
36. Rome ES, Ammerman S, Rosen DS, et al. Children and adolescents with eating disorders: the state of the art. Pediatrics 2003;111:e98-108.
37. Barrack MT, Ackerman KE, Gibbs JC. Update on the female athlete triad. Curr Rev Musculoskelet Med 2013;6:195-204.
38. Rumball JS, Lebrun CM. Preparticipation physical examination: selected issues for the female athlete. Clin J Sport Med 2004;14:153-60.
39. Rumball JS, Lebrun CM. Use of the preparticipation physical examination form to screen for the female athlete triad in Canadian interuniversity sport universities. Clin J Sport Med 2005;15:320-5.
40. Ljungqvist A, Jenoure P, Engebretsen L, et al. The International Olympic Committee (IOC) Consensus Statement on periodic health evaluation of elite athletes March 2009. Br J Sports Med 2009;43:631-43.
41. American Academy of Family Physicians, American Academy of Pediatrics, American College of Sports Medicine, American Medical Society for Sports Medicine, American Orthopaedic Society for Sports Medicine, American Osteopathic Academy of Sports Medicine. In: Roberts W, Bernhardt D. eds Preparticipation Physical Evaluation, chapter 3. Timing, setting and structure. Pages 11-17. 4th edn. Elk Grove, IL: American Academy of Pediatrics, 2010.
42. Mencias T, Noon M, Hoch AZ. Female athlete triad screening in National Collegiate Athletic Association Division I athletes: is the preparticipation evaluation form effective? Clin J Sport Med 2012;22:122-5.
43. Rauh MJ, Nichols JF, Barrack MT. Relationships among injury and disordered eating, menstrual dysfunction, and low bone mineral density in high school athletes: a prospective study. J Athl Train 2010;45:243-52.
44. Thein-Nissenbaum JM, Rauh MJ, Carr KE, et al. Menstrual irregularity and musculoskeletal injury in female high school athletes. J Athl Train 2012;47:74-82.
45. Matkovic V, Jelic T, Wardlaw GM, et al. Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model. J Clin Invest 1994;93:799-808.
46. Gibbs JC, Nattiv A, Barrack MT, et al. Low bone density risk is higher in exercising women with multiple Triad risk factors. Med Sci Sports Exerc 2014;46:167-76.
47. Francisco R, Narciso I, Alarcao M. Individual and relational risk factors for the development of eating disorders in adolescent aesthetic athletes and general adolescents. Eat Weight Disord 2013;18:403-11.
48. Gomes AR, Martins C, Silva L. Eating disordered behaviours in Portuguese athletes: the influence of personal, sport, and psychological variables. Eur Eat Disord Rev 2011;19:190-200.
49. Jacobi C, Fittig E, Bryson SW, et al. Who is really at risk? Identifying risk factors for subthreshold and full syndrome eating disorders in a high-risk sample. Psychol Med 2011;41:1939-49.
50. Rosen LW, Hough DO. Pathogenic weight-control behaviors of female college gymnasts. Phys Sports Med 1988;16:140.
51. Liechty JM, Lee MJ. Longitudinal predictors of dieting and disordered eating among young adults in the U. S. Int J Eat Disord 2013;46:790-800.
52. Sundgot-Borgen J. Risk and trigger factors for the development of eating disorders in female elite athletes. Med Sci Sports Exerc 1994;26:414-19.
53. Thompson RA, Sherman RT. "Good athlete" traits and characteristics of anorexia nervosa: are they similar? Eating Disord 1999;7:181-90.
54. Sundgot-Borgen J, Torstveit MK. Aspects of disordered eating continuum in elite high-intensity sports. Scand J Med Sci Sports 2010;20(Suppl 2):112-21.
55. Leon GR. Eating disorders in female athletes. Sports Med 1991;12:219-27.
56. Thein-Nissenbaum JM, Rauh MJ, Carr KE, et al. Associations between disordered eating, menstrual dysfunction, and musculoskeletal injury among high school athletes. J Orthop Sports Phys Ther 2011;41:60-9.
57. Diaz A, Laufer MR, Breech LL. Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Pediatrics 2006;118:2245-50.
58. Scholes D, La Croix AZ, Ichikawa LE, et al. Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception. Arch Pediatr Adolesc Med 2005;159:139-44.
59. Loud KJ, Micheli LJ, Bristol S, et al. Family history predicts stress fracture in active female adolescents. Pediatrics 2007;120:E364-72.
60. Herring SA, Kibler WB, Putukian M, and expert panel. Selected issues for nutrition and the athlete: a team physician consensus statement. Med Sci Sports Exerc 2013;45:2378-86.
61. Rodriguez NR, Di Marco NM, Langley S. American College of Sports Medicine position stand. Nutrition and athletic performance. Med Sci Sports Exerc 2009;41:709-31.
62. Deuster PA, Kyle SB, Moser PB, et al. Nutritional intakes and status of highly trained amenorrheic and eumenorrheic women runners. Fertil Steril 1986;46:636-43.
63. Kaiserauer S, Snyder AC, Sleeper M, et al. Nutritional, physiological, and menstrual status of distance runners. Med Sci Sports Exerc 1989;21:120-5.
64. Myerson M, Gutin B, Warren MP, et al. Resting metabolic rate and energy balance in amenorrheic and eumenorrheic runners. Med Sci Sports Exerc 1991;23:15-22.
65. Marcus R, Cann C, Madvig P, et al. Menstrual function and bone mass in elite women distance runners. Endocrine and metabolic features. Ann Intern Med 1985;102:158-63.
66. Le Grange D, Doyle PM, Swanson SA, et al. Calculation of expected body weight in adolescents with eating disorders. Pediatrics 2012;129:e438-46.
67. O'Donnell E, Harvey PJ, De Souza MJ. Relationships between vascular resistance and energy deficiency, nutritional status and oxidative stress in oestrogen deficient physically active women. Clin Endocrinol (Oxf) 2009;70:294-302.
68. Gibbs JC, Williams NI, Scheid JL, et al. The association of a high drive for thinness with energy deficiency and severe menstrual disturbances: confirmation in a large population of exercising women. Int J Sport Nutr Exerc Metab 2011;21:280-90.
69. Scheid JL, Williams NI, West SL, et al. Elevated PYY is associated with energy deficiency and indices of subclinical disordered eating in exercising women with hypothalamic amenorrhea. Appetite 2009;52:184-92.
70. De Souza MJ, Hontscharuk R, Olmsted M, et al. Drive for thinness score is a proxy indicator of energy deficiency in exercising women. Appetite 2007;48:359-67.
71. Heaney S, O'Connor H, Gifford J, et al. Comparison of strategies for assessing nutritional adequacy in elite female athletes' dietary intake. Int J Sport Nutr Exerc Metab 2010;20:245-56.
72. Ainsworth BE, Haskell WL, Herrmann SD, et al. 2011 Compendium of physical activities: a second update of codes and MET values. Med Sci Sports Exerc 2011;43:1575-81.
73. Koehler K, Braun H, De Marees M, et al. Parallel assessment of nutrition and activity in athletes: validation against doubly labelled water, 24-h urea excretion, and indirect calorimetry. J Sports Sci 2010;28:1435-49.
74. Toombs RJ, Ducher G, Shepherd JA, et al. The impact of recent technological advances on the trueness and precision of DXA to assess body composition. Obesity (Silver Spring) 2012;20:30-9.
75. Meyer NL, Sundgot-Borgen J, Lohman TG, et al. Body composition for health and performance: a survey of body composition assessment practice carried out by the Ad Hoc Research Working Group on Body Composition, Health and Performance under the auspices of the IOC Medical Commission. Br J Sports Med 2013;47:1044-53.
76. Illingworth P. Amenorrhea, anovulation, and dysfunctional uterine bleeding. In: Jameson JL, De Groot LJ. eds Endocrinology adult and pediatric. 6th edn. St. Louis, MO: Saunders, an affiliate of Elsevier, Inc., 2010:2341-55.
77. The Practice Committee of the American Society for Reproductive Medicine. Current evaluation of amenorrhea. Fertil Steril 2004;82(Suppl 1):S33-9.
78. De Souza MJ, Toombs RJ. Amenorrhea associated with the female athlete triad: etiology, diagnosis and treatment. In: Santoro NF, Neal-Perry G. eds Amenorrhea: a case-based, clinical guide. Springer Science+Business Media, 2010:101-27.
79. Legro RS, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2013;98:4565-92.
80. Lewiecki EM, Gordon CM, Baim S, et al. International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions. Bone 2008;43:1115-21.
81. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th edn. Arlington, VA: American Psychiatric Publishing, 2013.
82. Boden BP, Osbahr DC. High-risk stress fractures: evaluation and treatment. J Am Acad Orthop Surg 2000;8:344-53.
83. Marx RG, Saint-Phard D, Callahan LR, et al. Stress fracture sites related to underlying bone health in athletic females. Clin J Sport Med 2001;11:73-6.
84. Tannirandorn P, Epstein S. Drug-induced bone loss. Osteoporos Int 2000;11:637-59.
85. Malabanan AO, Rosen HN, Vokes TJ, et al. Indications of DXA in women younger than 65 years and men younger than 70 years: the 2013 Official Positions. J Clin Densitom 2013;16:467-71.
86. Gordon CM, Baim S, Bianchi ML, et al. Special report on the 2007 Pediatric Position Development Conference of the International Society for Clinical Densitometry. South Med J 2008;101:740-3.
87. Kopp-Woodroffe SA, Manore MM, Dueck CA, et al. Energy and nutrient status of amenorrheic athletes participating in a diet and exercise training intervention program. Int J Sport Nutr 1999;9:70-88.
88. Dueck CA, Matt KS, Manore MM, et al. Treatment of athletic amenorrhea with a diet and training intervention program. Int J Sport Nutr 1996;6:24-40.
89. Arends JC, Cheung MY, Barrack MT, et al. Restoration of menses with nonpharmacologic therapy in college athletes with menstrual disturbances: a 5-year retrospective study. Int J Sport Nutr Exerc Metab 2012;22:98-108.
90. Misra M, Prabhakaran R, Miller KK, et al. Weight gain and restoration of menses as predictors of bone mineral density change in adolescent girls with anorexia nervosa-1. J Clin Endocrinol Metab 2008;93:1231-7.
91. Golden NH, Jacobson MS, Schebendach J, et al. Resumption of menses in anorexia nervosa. Arch Pediatr Adolesc Med 1997;151:16-21.
92. Misra M, Prabhakaran R, Miller KK, et al. Role of cortisol in menstrual recovery in adolescent girls with anorexia nervosa. Pediatr Res 2006;59(4 Pt 1):598-603.
93. Misra M, Soyka LA, Miller KK, et al. Regional body composition in adolescents with anorexia nervosa and changes with weight recovery. Am J Clin Nutr 2003;77:1361-7.
94. Mallinson RJ, Williams NI, Olmsted MP, et al. A case report of recovery of menstrual function following a nutritional intervention in two exercising women with amenorrhea of varying duration. J Int Soc Sports Nutr 2013;10:34.
95. Miller KK, Lee EE, Lawson EA, et al. Determinants of skeletal loss and recovery in anorexia nervosa. J Clin Endocrinol Metab 2006;91:2931-7.
96. Audi L, Vargas DM, Gussinye M, et al. Clinical and biochemical determinants of bone metabolism and bone mass in adolescent female patients with anorexia nervosa. Pediatr Res 2002;51:497-504.
97. Hoch AZ, Jurva JW, Staton MA, et al. Athletic amenorrhea and endothelial dysfunction. WMJ 2007;106:301-6.
98. American Academy of Pediatrics. Medical concerns in the female athlete. Pediatrics 2000;106:610-13.
99. Temme KE, Hoch AZ. Recognition and rehabilitation of the female athlete triad/tetrad: a multidisciplinary approach. Curr Sports Med Rep 2013;12:190-9.
100. Sherman RT, Thompson RA. Practical use of the International Olympic Committee Medical Commission Position Stand on the Female Athlete Triad: a case example. Int J Eat Disord 2006;39:193-201.
101. Beals KA. Disordered eating among athletes: a comprehensive guide for health professionals. Champaign, IL: Human Kinetics, 2004.
102. Joy EA, Wilson C, Varechok S. The multidisciplinary team approach to the outpatient treatment of disordered eating. Curr Sports Med Rep 2003;2:331-6.
103. Sundgot-Borgen J. Weight and eating disorders in elite athletes. Scand J Med Sci Sports 2002;12:259-60.
104. Bratland-Sanda S, Sundgot-Borgen J. Eating disorders in athletes: overview of prevalence, risk factors and recommendations for prevention and treatment. Eur J Sport Sci 2013;13:499-508.
105. Zanker CL, Cooke CB, Truscott JG, et al. Annual changes of bone density over 12 years in an amenorrheic athlete. Med Sci Sports Exerc 2004;36:137-42.
106. Fredericson M, Kent K. Normalization of bone density in a previously amenorrheic runner with osteoporosis. Med Sci Sports Exerc 2005;37:1481-6.
107. Dominguez J, Goodman L, Sen Gupta S, et al. Treatment of anorexia nervosa is associated with increases in bone mineral density, and recovery is a biphasic process involving both nutrition and return of menses. Am J Clin Nutr 2007;86:92-9.
108. Joy E. Is the pill the answer for patients with the female athlete triad? Curr Sports Med Rep 2012;11:54-5.
109. Harris JA, Benedict FG. A biometric study of the basal metabolism in man. Washington, DC: Carnegie Institution of Washington, DC (Pub No 279), 1919:370-3.
110. Cunningham JJ. Body composition as a determinant of energy expenditure: a synthetic review and a proposed general prediction equation. Am J Clin Nutr 1991;54:963-9.
111. Frankenfield D, Roth-Yousey L, Compher C. Comparison of predictive equations for resting metabolic rate in healthy nonobese and obese adults: a systematic review. J Am Diet Assoc 2005;105:775-89.
112. Black AE, Coward WA, Cole TJ, et al. Human energy expenditure in affluent societies: an analysis of 574 doubly-labelled water measurements. Eur J Clin Nutr 1996;50:72-92.
113. FAO/WHO/UNU Expert Consultation. Energy and protein requirements. WHO Technical Report Series 724:1-206. Geneva: World Health Organization, 1985.
114. Reed JL, De Souza MJ, Williams NI. Changes in energy availability across the season in division I female soccer players. J Sports Sci 2013;31:314-24.
115. Jaffa T, Davies S, Sardesai A. What patients with anorexia nervosa should wear when they are being weighed: report of two pilot surveys. Eur Eat Disord Rev 2011;19:368-70.
116. Zach KN, Smith Machin AL, Hoch AZ. Advances in management of the female athlete triad and eating disorders. Clin Sports Med 2011;30:551-73.
117. Brownley KA, Berkman ND, Sedway JA, et al. Binge eating disorder treatment: a systematic review of randomized controlled trials. Int J Eat Disord 2007;40:337-48.
118. Shapiro JR, Berkman ND, Brownley KA, et al. Bulimia nervosa treatment: a systematic review of randomized controlled trials. Int J Eat Disord 2007;40:321-36.
119. Wilfley DE, Bishop ME, Wilson GT, et al. Classification of eating disorders: toward DSM-V. Int J Eat Disord 2007;40(Suppl):S123-9.
120. Berga SL, Marcus MD, Loucks TL, et al. Recovery of ovarian activity in women with functional hypothalamic amenorrhea who were treated with cognitive behavior therapy. Fertil Steril 2003;80:976-81.
121. Winters-Stone KM, Snow CM. Musculoskeletal response to exercise is greatest in women with low initial values. Med Sci Sports Exerc 2003;35:1691-6.
122. Misra M, Klibanski A. Bone health in anorexia nervosa. Curr Opin Endocrinol Diabetes Obes 2011;18:376-82.
123. Viapiana O, Gatti D, Dalle Grave R, et al. Marked increases in bone mineral density and biochemical markers of bone turnover in patients with anorexia nervosa gaining weight. Bone 2007;40:1073-7.
124. Bolton JG, Patel S, Lacey JH, et al. A prospective study of changes in bone turnover and bone density associated with regaining weight in women with anorexia nervosa. Osteoporos Int 2005;16:1955-62.
125. Compston JE, McConachie C, Stott C, et al. Changes in bone mineral density, body composition and biochemical markers of bone turnover during weight gain in adolescents with severe anorexia nervosa: a 1-year prospective study. Osteoporos Int 2006;17:77-84.
126. Heer M, Mika C, Grzella I, et al. Bone turnover during inpatient nutritional therapy and outpatient follow-up in patients with anorexia nervosa compared with that in healthy control subjects. Am J Clin Nutr 2004;80:774-81.
127. Hotta M, Shibasaki T, Sato K, et al. The importance of body weight history in the occurrence and recovery of osteoporosis in patients with anorexia nervosa: evaluation by dual X-ray absorptiometry and bone metabolic markers. Eur J Endocrinol 1998;139:276-83.
128. Ackerman KE, Nazem T, Chapko D, et al. Bone microarchitecture is impaired in adolescent amenorrheic athletes compared with eumenorrheic athletes and nonathletic controls. J Clin Endocrinol Metab 2011;96:3123-33.
129. Bailey CA, Brooke-Wavell K. Exercise for optimising peak bone mass in women. Proc Nutr Soc 2008;67:9-18.
130. Nikander R, Sievanen H, Heinonen A, et al. Femoral neck structure in adult female athletes subjected to different loading modalities. J Bone Miner Res 2005;20:520-8.
131. Ramsdale SJ, Bassey EJ. Changes in bone mineral density associated with dietary-induced loss of body mass in young women. Clin Sci (Lond) 1994;87:343-8.
132. Bassey EJ, Rothwell MC, Littlewood JJ, et al. Pre- and postmenopausal women have different bone mineral density responses to the same high-impact exercise. J Bone Miner Res 1998;13:1805-13.
133. Vainionpaa A, Korpelainen R, Leppaluoto J, et al. Effects of high-impact exercise on bone mineral density: a randomized controlled trial in premenopausal women. Osteoporos Int 2005;16:191-7.
134. Winters-Stone KM, Snow CM. Site-specific response of bone to exercise in premenopausal women. Bone 2006;39:1203-9.
135. Kato T, Terashima T, Yamashita T, et al. Effect of low-repetition jump training on bone mineral density in young women. J Appl Physiol 2006;100:839-43.
136. Martyn-St James M, Carroll S. Progressive high-intensity resistance training and bone mineral density changes among premenopausal women: evidence of discordant site-specific skeletal effects. Sports Med 2006;36:683-704.
137. Wallace BA, Cumming RG. Systematic review of randomized trials of the effect of exercise on bone mass in pre- and postmenopausal women. Calcif Tissue Int 2000;67:10-18.
138. Lanyon LE. Functional strain in bone tissue as an objective, and controlling stimulus for adaptive bone remodelling. J Biomech 1987;20:1083-93.
139. Rubin CT, Lanyon LE. Regulation of bone mass by mechanical strain magnitude. Calcif Tissue Int 1985;37:411-17.
140. Kelley GA, Kelley KS, Kohrt WM. Exercise and bone mineral density in premenopausal women: a meta-analysis of randomized controlled trials. Int J Endocrinol 2013;2013:741639.
141. Martyn-St James M, Carroll S. Effects of different impact exercise modalities on bone mineral density in premenopausal women: a meta-analysis. J Bone Miner Metab 2010;28:251-67.
142. Kelley GA, Kelley KS. Efficacy of resistance exercise on lumbar spine and femoral neck bone mineral density in premenopausal women: a meta-analysis of individual patient data. J Womens Health (Larchmt) 2004;13:293-300.
143. Chodzko-Zajko WJ, Proctor DN, Fiatarone Singh MA, et al. American College of Sports Medicine position stand. Exercise and physical activity for older adults. Med Sci Sports Exerc 2009;41:1510-30.
144. Misra M, Miller KK, Cord J, et al. Relationships between serum adipokines, insulin levels, and bone density in girls with anorexia nervosa. J Clin Endocrinol Metab 2007;92:2046-52.
145. Christo K, Prabhakaran R, Lamparello B, et al. Bone metabolism in adolescent athletes with amenorrhea, athletes with eumenorrhea, and control subjects. Pediatrics 2008;121:1127-36.
146. Petit MA, Beck TJ, Lin HM, et al. Femoral bone structural geometry adapts to mechanical loading and is influenced by sex steroids: the Penn State Young Women's Health Study. Bone 2004;35:750-9.
147. Loud KJ, Gordon CM, Micheli LJ, et al. Correlates of stress fractures among preadolescent and adolescent girls. Pediatrics 2005;115:e399-406.
148. Saxon LK, Turner CH. Estrogen receptor beta: the antimechanostat? Bone 2005;36:185-92.
149. Ducher G, Bass SL, Saxon L, et al. Effects of repetitive loading on the growth-induced changes in bone mass and cortical bone geometry: a 12-month study in pre/peri- and postmenarcheal tennis players. J Bone Miner Res 2011;26:1321-9.
150. Ackerman KE, Putman M, Guereca G, et al. Cortical microstructure and estimated bone strength in young amenorrheic athletes, eumenorrheic athletes and non-athletes. Bone 2012;51:680-7.
151. Drinkwater BL, Nilson K, Ott S, et al. Bone mineral density after resumption of menses in amenorrheic athletes. JAMA 1986;256:380-2.
152. Jonnavithula S, Warren MP, Fox RP, et al. Bone density is compromised in amenorrheic women despite return of menses: a 2-year study. Obstet Gynecol 1993;81(5 Pt 1):669-74.
153. Keen AD, Drinkwater BL. Irreversible bone loss in former amenorrheic athletes. Osteoporos Int 1997;7:311-15.
154. Nazem TG, Ackerman KE. The female athlete triad. Sports Health 2012;4:302-11.
155. American Psychiatric Association (APA). Practice guideline for the treatment of patients with eating disorders. 3rd edn. 2006. http:// psychiatryonline.org/pdfaccess. ashx?ResourceID=243187&PDFSource=6
156. Wanden-Berghe RG, Sanz-Valero J, Wanden-Berghe C. The application of mindfulness to eating disorders treatment: a systematic review. Eat Disord 2011;19:34-48.
157. Yager J, Devlin MJ, Halmi KA, et al. Guideline watch (August 2012): practice guideline for the treatment of patients with eating disorders. 3rd edn. American Psychiatric Association, 2012. http://psychiatryonline.org/pdfaccess. ashx? ResourceID=5391825&PDFSource=6
158. Aigner M, Treasure J, Kaye W, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders. World J Biol Psychiatry 2011;12:400-43.
159. Bergstrom I, Crisby M, Engstrom AM, et al. Women with anorexia nervosa should not be treated with estrogen or birth control pills in a bone-sparing effect. Acta Obstet Gynecol Scand 2013;92:877-80.
160. Warren MP, Brooks-Gunn J, Fox RP, et al. Persistent osteopenia in ballet dancers with amenorrhea and delayed menarche despite hormone therapy: a longitudinal study. Fertil Steril 2003;80:398-404.
161. Cobb KL, Bachrach LK, Sowers M, et al. The effect of oral contraceptives on bone mass and stress fractures in female runners. Med Sci Sports Exerc 2007;39:1464-73.
162. Gibson JH, Mitchell A, Reeve J, et al. Treatment of reduced bone mineral density in athletic amenorrhea: a pilot study. Osteoporos Int 1999;10:284-9.
163. Leung KC, Johannsson G, Leong GM, et al. Estrogen regulation of growth hormone action. Endocr Rev 2004;25:693-721.
164. Weissberger AJ, Ho KK, Lazarus L. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab 1991;72:374-81.
165. Hansen M, Miller BF, Holm L, et al. Effect of administration of oral contraceptives in vivo on collagen synthesis in tendon and muscle connective tissue in young women. J Appl Physiol 2009;106:1435-43.
166. Cobb KL, Bachrach LK, Greendale G, et al. Disordered eating, menstrual irregularity, and bone mineral density in female runners. Med Sci Sports Exerc 2003;35:711-19.
167. Strokosch GR, Friedman AJ, Wu SC, et al. Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in adolescent females with anorexia nervosa: a double-blind, placebo-controlled study. J Adolesc Health 2006;39:819-27.
168. Klibanski A, Biller BM, Schoenfeld DA, et al. The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab 1995;80:898-904.
169. Vescovi JD, Jamal SA, De Souza MJ. Strategies to reverse bone loss in women with functional hypothalamic amenorrhea: a systematic review of the literature. Osteoporos Int 2008;19:465-78.
170. Hartard M, Kleinmond C, Kirchbichler A, et al. Age at first oral contraceptive use as a major determinant of vertebral bone mass in female endurance athletes. Bone 2004;35:836-41.
171. Cumming DC. Exercise-associated amenorrhea, low bone density, and estrogen replacement therapy. Arch Intern Med 1996;156:2193-5.
172. Rickenlund A, Carlstrom K, Ekblom B, et al. Effects of oral contraceptives on body composition and physical performance in female athletes. J Clin Endocrinol Metab 2004;89:4364-70.
173. Rickenlund A, Thoren M, Nybacka A, et al. Effects of oral contraceptives on diurnal profiles of insulin, insulin-like growth factor binding protein-1, growth hormone and cortisol in endurance athletes with menstrual disturbance. Hum Reprod 2010;25:85-93.
174. Warren MP, Miller KK, Olson WH, et al. Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in women with hypothalamic amenorrhea and osteopenia: an open-label extension of a double-blind, placebo-controlled study. Contraception 2005;72:206-11.
175. De Cree C, Lewin R, Ostyn M. Suitability of cyproterone acetate in the treatment of osteoporosis associated with athletic amenorrhea. Int J Sports Med 1988;9:187-92.
176. Gremion G, Rizzoli R, Slosman D, et al. Oligo-amenorrheic long-distance runners may lose more bone in spine than in femur. Med Sci Sports Exerc 2001;33:15-21.
177. Hergenroeder AC, Smith EO, Shypailo R, et al. Bone mineral changes in young women with hypothalamic amenorrhea treated with oral contraceptives, medroxyprogesterone, or placebo over 12 months. Am J Obstet Gynecol 1997;176:1017-25.
178. Ohlsson C, Bengtsson BA, Isaksson OG, et al. Growth hormone and bone. Endocr Rev 1998;19:55-79.
179. Lebow J, Sim L. The influence of estrogen therapies on bone mineral density in premenopausal women with anorexia nervosa and amenorrhea. Vitam Horm 2013;92:243-57.
180. Misra M, Katzman D, Miller KK, et al. Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa. J Bone Miner Res 2011;26:2430-8.
181. Kam K, Park Y, Cheon M, et al. Effects of immobilization stress on estrogen-induced surges of luteinizing hormone and prolactin in ovariectomized rats. Endocrine 2000;12:279-87.
182. Cardim HJ, Lopes CM, Giannella-Neto D, et al. The insulin-like growth factor-I system and hormone replacement therapy. Fertil Steril 2001;75:282-7.
183. Massaro M, Di Carlo C, Gargano V, et al. Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study. Contraception 2010;81:209-14.
184. Massai R, Makarainen L, Kuukankorpi A, et al. The combined contraceptive vaginal ring and bone mineral density in healthy pre-menopausal women. Hum Reprod 2005;20:2764-8.
185. Rickenlund A, Eriksson MJ, Schenck-Gustafsson K, et al. Oral contraceptives improve endothelial function in amenorrheic athletes. J Clin Endocrinol Metab 2005;90:3162-7.
186. Wiren KM, Zhang XW, Olson DA, et al. Androgen prevents hypogonadal bone loss via inhibition of resorption mediated by mature osteoblasts/osteocytes. Bone 2012;51:835-46.
187. Riggs BL, Khosla S, Melton LJ 3rd. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 2002;23:279-302.
188. Abu EO, Horner A, Kusec V, et al. The localization of androgen receptors in human bone. J Clin Endocrinol Metab 1997;82:3493-7.
189. Miller KK, Meenaghan E, Lawson EA, et al. Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study. J Clin Endocrinol Metab 2011;96:2081-8.
190. Welt CK, Chan JL, Bullen J, et al. Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med 2004;351:987-97.
191. Sienkiewicz E, Magkos F, Aronis KN, et al. Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women. Metabolism 2011;60:1211-21.
192. Chou SH, Chamberland JP, Liu X, et al. Leptin is an effective treatment for hypothalamic amenorrhea. Proc Natl Acad Sci USA 2011;108:6585-90.
193. Misra M, McGrane J, Miller KK, et al. Effects of rhIGF-1 administration on surrogate markers of bone turnover in adolescents with anorexia nervosa. Bone 2009;45:493-8.
194. Grinspoon S, Thomas L, Miller K, et al. Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab 2002;87:2883-91.
195. Kluge M, Schussler P, Uhr M, et al. Ghrelin suppresses secretion of luteinizing hormone in humans. J Clin Endocrinol Metab 2007;92:3202-5.
196. Lu M, Tang Q, Olefsky JM, et al. Adiponectin activates adenosine monophosphate-activated protein kinase and decreases luteinizing hormone secretion in LbetaT2 gonadotropes. Mol Endocrinol 2008;22:760-71.
197. Wen JP, Lv WS, Yang J, et al. Globular adiponectin inhibits GnRH secretion from GT1-7 hypothalamic GnRH neurons by induction of hyperpolarization of membrane potential. Biochem Biophys Res Commun 2008;371:756-61.
198. Wong IP, Driessler F, Khor EC, et al. Peptide YY regulates bone remodeling in mice: a link between gut and skeletal biology. PLoS ONE 2012;7:e40038.
199. Luo XH, Guo LJ, Xie H, et al. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res 2006;21:1648-56.
200. Vulliemoz NR, Xiao E, Xia-Zhang L, et al. Decrease in luteinizing hormone pulse frequency during a five-hour peripheral ghrelin infusion in the ovariectomized rhesus monkey. J Clin Endocrinol Metab 2004;89:5718-23.
201. Watts NB, Lewiecki EM, Miller PD, et al. National Osteoporosis Foundation 2008 Clinician's Guide to Prevention and Treatment of Osteoporosis and the World Health Organization Fracture Risk Assessment Tool (FRAX): what they mean to the bone densitometrist and bone technologist. J Clin Densitom 2008;11:473-7.
202. Forwood MR, Burr DB. Physical activity and bone mass: exercises in futility? Bone Miner 1993;21:89-112.
203. Nikander R, Sievanen H, Uusi-Rasi K, et al. Loading modalities and bone structures at nonweight-bearing upper extremity and weight-bearing lower extremity: a pQCT study of adult female athletes. Bone 2006;39:886-94.
204. Estrada K, Styrkarsdottir U, Evangelou E, et al. Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet 2012;44:491-501.
205. Marini JC. Do bisphosphonates make children's bones better or brittle? N Engl J Med 2003;349:423-6.
206. Papapoulos SE, Cremers SC. Prolonged bisphosphonate release after treatment in children. N Engl J Med 2007;356:1075-6.
207. Desai PA, Vyas PA, Lane JM. Atypical Femoral fractures: a review of the literature. Curr Osteoporos Rep 2013;11:179-87.
208. Shane E, Burr D, Abrahamsen B, et al. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2013 May 28. doi:10.1002/jbmr.1998
209. Khosla S, Burr D, Cauley J, et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2007;22:1479-91.
210. Golden NH, Iglesias EA, Jacobson MS, et al. Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2005;90:3179-85.
211. Hoshino H, Takahashi M, Kushida K, et al. The relationships between the degree of beta-isomerization of type I collagen degradation products in the urine and aging, menopause and osteoporosis with fractures. Osteoporos Int 1999;9:405-9.
212. Bishop N, Adami S, Ahmed SF, et al. Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial. Lancet 2013.
213. Rizzoli R, Adachi JD, Cooper C, et al. Management of glucocorticoid- induced osteoporosis. Calcif Tissue Int 2012;91:225-43.
214. Bachrach LK, Ward LM. Clinical review 1: bisphosphonate use in childhood osteoporosis. J Clin Endocrinol Metab 2009;94:400-9.
215. Bachrach LK, Sills IN. Clinical report-bone densitometry in children and adolescents. Pediatrics 2011;127:189-94.
216. Fazeli P, Wang I, Miller K, et al. Teriparatide increases bone formation and bone mineral density in adult women with anorexia nervosa. American Society of Bone and Mineral Research Annual Meeting 2013; Baltimore, MD [Abstract LB-SA33].
217. Raghavan P, Christofides E. Role of teriparatide in accelerating metatarsal stress fracture healing: a case series and review of literature. Clin Med Insights Endocrinol Diabetes 2012;5:39-45.
218. Goolsby MA, Nattiv AN, Casper J. Predictors for stress fracture and stress fracture rate in male and female collegiate track athletes: a prospective analysis. American Medical Society for Sports Medicine Annual Meeting. 2008.
219. Okamoto S, Arai Y, Hara K, et al. A displaced stress fracture of the femoral neck in an adolescent female distance runner with female athlete triad: a case report. Sports Med Arthrosc Rehabil Ther Technol 2010;2:6.
220. Whiting SJ, Vatanparast H, Baxter-Jones A, et al. Factors that affect bone mineral accrual in the adolescent growth spurt. J Nutr 2004;134:696S-700S.
221. Institute of Medicine. Dietary reference intakes for calcium and vitamin D. National Academy of Sciences; November 2010, Report Brief. http://wwwiomedu/~/media/Files/Report%20Files/2010/Dietary-Reference-Intakes- for-Calcium-and-Vitamin-D/Vitamin%20D%20and%20Calcium%202010%20Report%20Briefpdf
222. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911-30.
223. Food and Drug Administration. Prometrium Label. http://www.accessdata. fda.gov/drugsatfda-docs/label/2009/019781s013lbl.pdf
224. Medroxyprogesterone Dosage. Drugs. com. http://www.drugs.com/dosage/ medroxyprogesterone.html
225. MacLennan AH. HRT in difficult circumstances: are there any absolute contraindications? Climacteric 2011;14:409-17.
226. Oswald AJ, Berg J, Milne G, et al. Teriparatide treatment of severe osteoporosis reduces the risk of vertebral fractures compared with standard care in routine clinical practice. Calcif Tissue Int 2013.
227. Eriksen EF, Halse J, Moen MH. New developments in the treatment of osteoporosis. Acta Obstet Gynecol Scand 2013;92:620-36.
228. Yeager KK, Agostini R, Nattiv A, et al. The female athlete triad: disordered eating, amenorrhea, osteoporosis. Med Sci Sports Exerc 1993;25:775-7.
229. Herring SA, Kibler WB, Putukian M. The team physician and the return-to-play decision: a consensus statement-2012 update. Med Sci Sports Exerc 2012;44:2446-8.
230. Kanis JA, Johnell O, Oden A, et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008;19:385-97.
231. McCloskey E, Kanis JA. FRAX updates 2012. Curr Opin Rheumatol 2012;24:554-60.
232. Herring SA, Kibler WB, Putukian M. Team Physician Consensus Statement: 2013 update. Med Sci Sports Exerc 2013;45:1618-22.
233. Creighton DW, Shrier I, Shultz R, et al. Return-to-play in sport: a decision-based model. Clin J Sport Med 2010;20:379-85.
234. Torstveit MK, Sundgot-Borgen J. Participation in leanness sports but not training volume is associated with menstrual dysfunction: a national survey of 1276 elite athletes and controls. Br J Sports Med 2005;39:141-7.
235. Kasa-Vubu JZ, Rosenthal A, Murdock EG, et al. Impact of fatness, fitness, and ethnicity on the relationship of nocturnal ghrelin to 24-hour luteinizing hormone concentrations in adolescent girls. J Clin Endocrinol Metab 2007;92:3246-52.
236. Caine D, Di Fiori J, Maffulli N. Physeal injuries in children's and youth sports: reasons for concern? Br J Sports Med 2006;40:749-60.
237. Goolsby MA, Barrack MT, Nattiv A. A displaced femoral neck stress fracture in an amenorrheic adolescent female runner. Sports Health 2012;4:352-6.
238. Haddad FS, Bann S, Hill RA, et al. Displaced stress fracture of the femoral neck in an active amenorrhoeic adolescent. Br J Sports Med 1997;31:70-2.
239. Smink FR, van Hoeken D, Hoek HW. Epidemiology of eating disorders: incidence, prevalence and mortality rates. Curr Psychiatry Rep 2012;14:406-14.
240. Zipfel S, Lowe B, Reas DL, et al. Long-term prognosis in anorexia nervosa: lessons from a 21-year follow-up study. Lancet 2000;355:721-2.
241. Franko DL, Keshaviah A, Eddy KT, et al. A longitudinal investigation of mortality in anorexia nervosa and bulimia nervosa. Am J Psychiatry 2013;170:917-25.
242. Matheson GO, Shultz R, Bido J, et al. Return-to-play decisions: are they the team physician's responsibility? Clin J Sport Med 2011;21:25-30.